Several companies released diabetes study results this week, while companies like BioTime closed on their public offerings and Pixium implanted its first bionic eye. Here are 7 medtech stories we missed this week, but were still worth mentioning. 1. Insulet touts glucose control study Insulet Corp. announced the results from its first feasibility study of its Omnipod […]
Valeritas yesterday rekindled its plans for an initial public offering, but scaled its ambitions back by some $25 million. Bridgewater, N.J.-based Valeritas makes the V-Go basal insulin delivery system for Type II diabetes, a fully disposable, continuous-delivery device that’s designed to function for 24 hours based on a preset rate, with on-demand dosing for meals. Valeritas […]
Xtant Medical (NYSE:XTNT) said that CEO Dan Goldberger resigned effective Jan. 21 “to pursue other interests.” The Belgrade, Mont.-based company, which was formed after Bacterin paid $86 million for spinal implant maker X-Spine Systems, said president Carl O’Connell will step in as interim CEO while the company’s board “contemplates the permanent CEO,” according to a […]
Getinge ousts CEO Myers after 18 months, shares slide After less than 18 months in the corner office, Getinge (PINK:GETI B) has removed CEO Alex Myers from his position, sending shares down as much as 6% in trading. The shift was due to “different views” on the direction of the company, and changes are going into […]
Valeritas said today it raised $25 million through an “alternative public offering” via a reverse merger and the private placement of 5 million shares of unregistered stock at $5 per share. Through the reverse merger, Valeritas will trade on the OTC market under the symbol “VLRX” and will continue to operate business as usual, the Bridgewater, […]
Flex taps ex J&J med device R&D exec Carlson for Flex Med Solutions prez Flex (NSDQ:FLEX) said it hired ex-Johnson & Johnson (NYSE:JNJ) innovation portfolio veep as its new president of Flex Medical solutions. The position will put Carlson in charge of the company’s $8 billion research & development budget across pharmaceuticals, medical devices and consumer […]
Nearly a year after tabling a proposed initial public offering, Valeritas today formally withdrew the planned flotation in a regulatory filing. “The market conditions have been such that the offering of registrant’s common stock will not be consummated, and there have been no public offering activities by the registrant for at least the last several months,” […]
Alfred Mann, a medical device entrepreneur who helped develop several groundbreaking technologies, died yesterday at age 90, shortly after stepping down from a pair of companies he founded. Mann founded 17 companies over his 70-year career, in industries ranging from aerospace to medtech, according to the L.A. Times. After Johns Hopkins University researchers in 1969 […]
Valeritas said today that data from a study of its V-Go insulin pump showed a significant decrease in A1C levels after 14 and 27-week follow-up visits. Data from the study was published in the journal Diabetes Therapy this week, the company said. “Tight glycemic control and timely treatment can improve outcomes in patients with diabetes, yet many […]
Medtronic (NYSE:MDT) and Intarcia Therapeutics were in the spotlight at the American Diabetes Assn.’s annual scientific sessions conference in Boston last week, revealing new medical device developments in the fight against diabetes. Medtronic took center stage, announcing new developments for its artificial pancreas program, touting positive data from a user study of its MiniMed 640g and revealing plans to collaborate […]
Valeritas touted real-world data from 3 separate studies of its V-Go insulin delivery system showcasing the device’s utility and effectiveness.
V-Go is a disposable, wearable insulin delivery device designed to deliver a preset dosage continually over 24 hours and on-demand doses during meals.